Trials / Completed
CompletedNCT01322464
Study to Assess Food Effect on Sativex Bioavailability
A Phase I Study to Assess the Effect of Food on the Single-Dose Bioavailability of Sativex, and to Compare the Single and Multiple Dose Pharmacokinetics of Sativex at Three Dose Levels
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 25 (actual)
- Sponsor
- Jazz Pharmaceuticals · Industry
- Sex
- Male
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
Study to assess effect of food on the bioavailability of a single dose of Sativex and to measure its' pharmacokinetics after a single and multiple doses.
Detailed description
This was an open-label, randomised, ascending dose, 2-way crossover food-effect study incorporating a parallel single and multiple dose components in healthy subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Sativex | 4 sprays Sativex in fasted state on Day 1. 4 sprays Sativex in fed state on Day 4. 4 sprays Sativex daily in fasted state Days 5-13. |
| DRUG | Sativex | 4 sprays Sativex in fed state on Day 1. 4 sprays Sativex in fasted state on Day 4. 4 sprays Sativex daily in fasted state Days 5-13. |
| DRUG | Sativex | 2 sprays Sativex daily in fasted state Days 4-13. |
| DRUG | Sativex | 8 sprays Sativex daily in fasted state Days 4-13. |
Timeline
- Start date
- 2008-01-01
- Primary completion
- 2008-02-01
- Completion
- 2008-02-01
- First posted
- 2011-03-24
- Last updated
- 2023-04-10
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT01322464. Inclusion in this directory is not an endorsement.